EMEA-001082-PIP02-11-M03
Key facts
Invented name |
Holoclar
|
Active substance |
Ex vivo expanded autologous human corneal epithelium cells containing stem cells
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0066/2022
|
PIP number |
EMEA-001082-PIP02-11-M03
|
Pharmaceutical form(s) |
Living tissue equivalent
|
Condition(s) / indication(s) |
Treatment of limbal stem cell deficiency due to ocular burns
|
Route(s) of administration |
Ophthalmic use
|
Contact for public enquiries |
Holostem Terapie Avanzate S.r.l.
+39 3492403930 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|